Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynorphin 1-13 for Heroin Withdrawal
NCT00000244Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Aug 1994
- Primary completion
- Mar 1997
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dynorphin A 1-13 in opioid withdrawal syndrome (OWS) (4 arms), sponsored by University of Minnesota. Primary endpoint: Craving scale. Started Aug 1994; status: completed.
02
Drugs
dynorphin A 1-13
03
Conditions
opioid withdrawal syndrome (OWS)
Beyond the preview
Go deeper on NCT00000244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000244.